ReviewClinical and translational science2022

Evolution of preclinical characterization and insights into clinical pharmacology of checkpoint inhibitors approved for cancer immunotherapy.

Sreeneeranj Kasichayanula et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.